IP Library Patent Application 11441837
Patent Application
App. No. 11/441,837

Methods and compositions for defining gene function

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/441,837
Abstract

The present invention relates to a process for the efficient and practical production and analysis of mutated mouse ES cell clones useful for defining the physiological role of genetically encoded biopolymers and for the in vivo testing for enhanced resistance or sensitivity to injury challenge or other physiological insult.

Claims (11)

1 . A process for identifying genes involved in injury repair or enhanced sensitivity to injury, comprising:

a) subjecting a collection of at least about 40 distinct genetically engineered knockout mouse lines to an injury challenge; and

b) measuring the surviving Ki67 positive cell population.

2 . The process of claim 1 wherein said injury challenge is by ionizing radiation.

3 . The process of claim 1 wherein said injury challenge is by a chemotherapeutic agent.

4 . The process of claim 1 wherein said injury challenge is at a sublethal dose.

5 . A process for identifying genes encoding products that modulate neurodegeneration, comprising:

a) subjecting a mouse to a source of neuronal damage;

b) measuring the surviving Ki67 positive cell population; and

c) using an additional marker to screen for Ki67 positive cells that are not of neuronal lineage.

6 . A process according to claim 5 wherein said additional marker is drawn from the group consisting of double cortin, class III beta tubulin, and polysialylated neural cell adhesion molecule.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2006
From: SMALL, DANIEL L.; SANDS, ARTHUR T.
To: LEXICON GENETICS INCORPORATED
Reel/Frame 018214/0846 →